| Literature DB >> 26818683 |
Elena Heber1, Dirk Lehr, David Daniel Ebert, Matthias Berking, Heleen Riper.
Abstract
BACKGROUND: Work-related stress is highly prevalent among employees and is associated with adverse mental health consequences. Web-based interventions offer the opportunity to deliver effective solutions on a large scale; however, the evidence is limited and the results conflicting.Entities:
Keywords: Internet; mental health; randomized controlled trial; stress; stress management; work
Mesh:
Year: 2016 PMID: 26818683 PMCID: PMC4749847 DOI: 10.2196/jmir.5112
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Flow of participants.
Baseline characteristics.
| Characteristics | All participants (n=264) | iSMI (n=132) | WLC (n=132) | |
|
| ||||
|
| Age, mean (SD) | 43.3 (10.2) | 42.4 (10.7) | 44.2 (9.6) |
|
| Gender, female, n (%) | 193 (73.1) | 97 (73.5) | 96 (72.7) |
|
| Married or in a relationship, n (%) | 160 (60.6) | 80 (60.6) | 80 (60.6) |
|
| ||||
|
| Caucasian/white | 220 (83.3) | 110 (83.3) | 110 (83.3) |
|
| Prefer not to say | 44 (16.7) | 22 (16.7) | 22 (16.7) |
|
| ||||
|
| Low | 5 (1.9) | 3 (2.3) | 2 (1.5) |
|
| Middle | 56 (21.2) | 25 (18.9) | 31 (23.5) |
|
| High | 203 (76.9) | 104 (78.8) | 99 (75.0) |
|
| ||||
|
| Full-time employed, n (%) | 204 (77.3) | 105 (79.5) | 99 (75.0) |
|
| Part-time employed, n (%) | 57 (21.6) | 25 (18.9) | 32 (24.2) |
|
| On sick leave, n (%) | 3 (1.1) | 2 (1.5) | 1 (0.8) |
|
| Work experience in years, mean (SD) | 18.1 (11.1) | 17.2 (10.8) | 18.9 (11.2) |
|
| ||||
|
| Social | 97 (36.7) | 48 (36.4) | 49 (37.1) |
|
| Service | 43 (16.3) | 21 (15.9) | 22 (16.7) |
|
| Health | 36 (13.6) | 22 (16.7) | 14 (10.6) |
|
| Economy | 31 (11.7) | 14 (10.6) | 17 (12.9) |
|
| IT | 15 (5.7) | 8 (6.1) | 7 (5.3) |
|
| Others | 42 (16.0) | 19 (14.3) | 23 (17.4) |
|
| ||||
|
| <10,000 | 10 (3.8) | 7 (5.3) | 3 (2.3) |
|
| 10,000-30,000 | 48 (18.2) | 28 (21.2) | 20 (15.2) |
|
| 30,000-40,000 | 63 (23.9) | 26 (19.7) | 37 (28.0) |
|
| 40,000-50,000 | 47 (17.8) | 26 (19.7) | 21 (15.9) |
|
| 50,000-60,000 | 29 (11.0) | 15 (11.4) | 14 (10.6) |
|
| 60,000-100,00 | 32 (12.1) | 17 (12.9) | 15 (11.4) |
|
| >100,000 | 4 (1.5) | 1 (0.8) | 3 (2.3) |
|
| Prefer not to say | 31 (11.7) | 12 (9.1) | 19 (14.4) |
|
| ||||
|
| Previous health training | 34 (12.9) | 17 (12.9) | 17 (12.9) |
|
| Previous psychotherapy | 95 (36.0) | 52 (39.4) | 43 (32.6) |
|
| Current psychotherapy | 16 (6.1) | 5 (3.8) | 11 (8.3) |
Means and standard deviations for the iSMI group and the WLC group (ITT sample).
|
| T1 | T2a | T3a | T4a,b | |||||||||||
| iSMI | WLC | iSMI | WLC | iSMI | WLC | iSMI | |||||||||
| Outcome | M | SD | M | SD | M | SD | M | SD | M | SD | M | SD | M | SD | |
|
| |||||||||||||||
|
| PSS-10 | 25.89 | 3.85 | 25.15 | 3.96 | 17.88 | 6.17 | 22.96 | 6.07 | 16.08 | 6.03 | 22.10 | 5.81 | 16.25 | 6.35 |
|
| |||||||||||||||
|
| CES-D | 23.34 | 8.47 | 23.77 | 7.59 | 15.61 | 9.09 | 21.35 | 8.82 | 13.83 | 7.71 | 21.49 | 8.48 | 14.56 | 8.71 |
|
| ISI | 15.53 | 6.62 | 14.82 | 6.48 | 8.79 | 5.81 | 11.20 | 6.15 | 8.18 | 5.58 | 11.00 | 5.35 | 7.82 | 4.95 |
|
| HADS-A | 11.23 | 3.34 | 10.67 | 3.36 | 7.79 | 3.98 | 10.32 | 3.46 | 6.73 | 3.38 | 9.65 | 3.58 | 6.51 | 3.46 |
|
| PSWQ-PW | 10.17 | 3.98 | 10.23 | 3.74 | 6.82 | 3.99 | 8.91 | 4.21 | 6.08 | 3.78 | 8.65 | 4.36 | 5.83 | 3.82 |
|
| SF-12 MHc | 32.29 | 8.44 | 32.55 | 8.08 | N/A | N/A | N/A | N/A | 43.38 | 10.56 | 36.54 | 9.50 | 44.16 | 9.69 |
|
| SF-12 PHc | 48.24 | 10.05 | 48.44 | 9.43 | N/A | N/A | N/A | N/A | 49.23 | 8.17 | 47.57 | 8.75 | 49.27 | 6.39 |
|
| |||||||||||||||
|
| MBI-EE | 4.73 | 0.68 | 4.77 | 0.67 | 3.95 | 1.03 | 4.64 | 0.80 | 3.70 | 1.01 | 4.54 | 0.95 | 3.67 | 0.95 |
|
| UWESc | 3.18 | 1.26 | 3.31 | 1.15 | 3.38 | 1.29 | 3.10 | 1.13 | 3.46 | 1.17 | 3.16 | 1.14 | 3.46 | 1.13 |
|
| REQ-PDc | 2.11 | 0.81 | 2.16 | 0.85 | 2.75 | 0.91 | 2.26 | 0.92 | 3.06 | 0.95 | 2.38 | 0.87 | 2.97 | 0.88 |
|
| Absenteeismd | 4.93 | 8.70 | 4.40 | 9.62 | N/A | N/A | N/A | N/A | 3.64 | 6.70 | 5.23 | 12.10 | 5.88 | 10.57 |
|
| Presenteeismd | 15.98 | 14.27 | 17.29 | 16.51 | N/A | N/A | N/A | N/A | 11.32 | 12.88 | 11.47 | 11.93 | 8.22 | 9.59 |
|
| |||||||||||||||
|
| ERSQ-Cc | 2.48 | 0.88 | 2.47 | 0.86 | 3.01 | 0.70 | 2.57 | 0.90 | 3.15 | 0.64 | 2.78 | 0.80 | 3.16 | 0.70 |
|
| ERSQ-Ac | 1.95 | 0.93 | 1.98 | 0.79 | 2.64 | 0.76 | 2.16 | 0.85 | 2.84 | 0.78 | 2.31 | 0.88 | 2.82 | 0.78 |
|
| ERSQ-SSc | 2.02 | 0.91 | 2.15 | 0.82 | 2.70 | 0.73 | 2.32 | 0.88 | 2.79 | 0.82 | 2.38 | 0.86 | 2.73 | 0.86 |
|
| ERSQ-ES-GDc | 1.79 | 0.54 | 1.81 | 0.52 | 2.43 | 0.56 | 2.04 | 0.59 | 2.53 | 0.58 | 2.04 | 0.55 | 2.58 | 0.52 |
aMissing data imputed by multiple imputation.
bExtended follow-up for intervention group only.
cHigher scores indicate better outcomes.
dIn relation to the previous 3 months.
Results of the ANCOVAs and Cohen’s d for the primary and secondary outcome measures (ITT sample) at posttest (T2) and at 6-month follow-up (T3).
| Outcome | T2a Between-groups effect | T3a Between-groups effect | |||||
|
| ANCOVAb |
| ANCOVAb | ||||
|
|
|
|
| ||||
|
| |||||||
|
| PSS-10 | 0.83 (0.58-1.08) | 58.08 | <.001 | 1.02 (0.76-1.27) | 80.17 | <.001 |
|
| |||||||
|
| CES-D | 0.64 (0.39-0.89) | 34.92 | <.001 | 0.95 (0.69-1.20) | 68.29 | <.001 |
|
| ISI | 0.40 (0.16-0.65) | 20.43 | <.001 | 0.52 (0.27-0.76) | 28.82 | <.001 |
|
| HADS-A | 0.68 (0.43-0.93) | 49.57 | <.001 | 0.84 (0.59-1.09) | 78.94 | <.001 |
|
| PSWQ-PW | 0.51 (0.26-0.75) | 19.74 | <.001 | 0.63 (0.38-0.88) | 31.00 | <.001 |
|
| SF-12 MH | N/A | N/A |
| 0.68 (0.43-0.93) | 34.28 | <.001 |
|
| SF-12 PH | N/A | N/A |
| 0.20 (-0.05 to 0.44) | 4.27 | .04 |
|
| |||||||
|
| MBI-EE | 0.75 (0.50-1.00) | 48.55 | <.001 | 0.86 (0.60-1.11) | 63.84 | <.001 |
|
| UWES | 0.23 (-0.01 to 0.47) | 13.28 | <.001 | 0.26 (0.02-0.50) | 10.09 | .002 |
|
| REQ-PD | 0.54 (0.29-0.78) | 27.45 | <.001 | 0.75 (0.50-1.00) | 52.82 | <.001 |
|
| Absenteeism | N/A | N/A |
| 0.16 (-0.08 to 0.40) | 2.94 |
|
|
| Presenteeism | N/A | N/A |
| 0.01 (-0.23 to 0.25) | 0.02 |
|
|
| |||||||
|
| ERSQ-27-C | 0.55 (0.30-0.79) | 31.56 | <.001 | 0.51 (0.27-0.76) | 22.03 | <.001 |
|
| ERSQ-27-A | 0.60 (0.35-0.84) | 30.94 | <.001 | 0.64 (0.39-0.88) | 34.96 | <.001 |
|
| ERSQ-27-SS | 0.47 (0.23-0.71) | 29.32 | <.001 | 0.49 (0.24-0.73) | 24.56 | <.001 |
|
| ERSQ-ES-GD | 0.68 (0.43-0.93) | 36.39 | <.001 | 0.87 (0.61-1.12) | 54.71 | <.001 |
aMissing data imputed by multiple imputation.
bControlling for pre-treatment scores (T1).
Figure 2Levels of perceived stress (means and SDs) according to the PSS-10 for the iSMI and WLC groups at all assessment points for the ITT sample at pre-test (T1), post-test (T2), 6 months (T3), and 12 months (T4, iSMI only) (asterisks indicate P<.001).